A UK startup using AI to help scientists decide what to make
North East England Since 2019
We focus on leveraging artificial intelligence to design and modify proteins and small molecules.
01 · Who we are & what we do
BlueDopamine is a young company in North East England building AI tools for protein, enzyme and peptide design. We combine design, biological context and a clear record of every decision, so small research teams can work with the confidence of a much larger lab.
BlueDopamine is a trailblazer in the biotechnology industry, focused on leveraging artificial intelligence to revolutionize the design of proteins, vaccines, and drugs. Our core mission is to harness the power of advanced AI algorithms and molecular modeling to push the boundaries of protein engineering. We provide innovative solutions that enable precise, efficient, and customizable biomolecule design for a range of applications in medicine, environmental sustainability, and beyond. By blending cutting-edge technology with deep biological insights, BlueDopamine is not just responding to the challenges of today but is actively shaping the future of healthcare and biotechnology.
02 · Mission
Help researchers choose the right candidates to test, and show their reasoning.
03Our story
2019–2026
Y01
2019
Start of the JourneyWe embarked on our mission to revolutionize protein and molecule design with AI, initiating research on developing our platform.
Y02
2020
Start Development of Molecule Design ModelBegan crafting an AI model focused on accelerating the discovery and design of novel molecules.
Y03
2021
Protein Design Model DevelopmentWe initiated the development of an AI-driven protein design model to engineer novel proteins with bespoke functionalities.
Y04
2022
Protein-Drug Interaction Model DevelopmentWe started creating a model to predict protein-drug interactions, aiming to enhance the development of safer, more effective drugs.
Y05
2023
Starting Evaluating Our ModelsWe began evaluating our platform by granting access to some academics, who are assessing its utility in their projects.
Y06
2026
The company is based in the UK
04Recognition
4 awards
BlueDopamine has quickly gained attention for its innovative approach to AI in medicine. The startup’s work has been recognised through the awards showcased in this section.
These accolades underscore BlueDopamine’s position at the forefront of AI in medicine, with judges and industry experts citing its innovative approach to key parts of molecular modelling and protein engineering.
A01 · 2025
Winner · 2025Rayan AI CompetitionHosted by Sharif University
A02 · 2024
Runner-up · 2024Elecomp Stars Pitch CompetitionThe biggest startup competition of Iran, held in the Elecomp exhibition, the largest exhibition for electronic and computer products
A03 · 2024
Runner-up · 2024Inotex Pitch CompetitionOne of the most important international innovation and startup platforms of Iran
A04 · 2023
Winner · 2023Iran Artificial Intelligence Awards (IAAA)Held in Tehran
05Where we are
Newcastle · North East England
Based at Northumbria University's start-up programme in Newcastle.